From the timeline map of keywords, we found that studies have focused on insulin sensitivity, prediabetic high-risk diseases (polycystic ovary syndrome (PCOS), coronary artery disease, dyslipidemia) and lifestyle interventions. This evidence concerns the gene INS and metabolic syndrome.